Sunday, January 5, 2025

Week in Review 1/25



 

Welcome and thanks for reading!

In this review, I will make a summary of important and interesting news and events over the last week related to my portfolio holdings. Also, I will put together some interesting articles from other websites that caught my attention during the past week.



Received Dividends:



December 30, 2024


  • €22.03 – Gilead Sciences, Inc. (GILD)
  • €21.08 – Union Pacific Corporation (UNP)
  • €33.17 – Main Street Capital Corporation (MAIN)
  • €67.34 – Ares Capital Corporation (ARCC)


December 31, 2024


  • €18.02 – Eversource Energy (ES)
  • €13.56 – LTC Properties, Inc. (LTC)
  • €58.88 – PPL Corporation (PPL)
  • €14.85 – Canadian National Railway Company (CNR)



January 2, 2025


  • €32.27 – UGI Corporation (UGI)
  • €7.38 – Baxter International Inc. (BAX)
  • €76.73 – TELUS Corporation (TSE:T)



Week 1: Total net dividends €365.30



Dividend income is reported after the deduction of taxes. Check more at my Monthly Dividend sheet.



My Portfolio's Transactions:



January 3, 2025



  • I purchased 30 shares of Bank OZK (OZK) at $43.20 per share plus commission.


At today's exchange rate, that purchase 30 shares of OZK will increase €36.41 of my expected annual net dividend income. Following this acquisition, the portfolio now contains a total of 100 Bank OZK shares at an average purchase price of $40.37 and yield on cost is 4.16%. After this acquisition, OZK ’s weight of my portfolio is about 0.29% and its share of future annual dividend income is approximately 0.58%.



Portfolio Holdings News:



December 30, 2024


  • Orion Corporation (ORION) and Marinus terminate agreement for ganaxolone in Europe; ORION and Marinus Pharmaceuticals, Inc. have decided to mutually terminate their European wide marketing and distribution agreement for ganaxolone. Marinus regains ganaxolone’s commercial rights in Europe where the compound is approved for the adjunctive treatment of epileptic seizures associated with cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD) in patients two to 17 years of age.


January 2, 2025


  • Bank OZK (OZK) Announces Increase to Quarterly Dividend; OZK announced its Board of Directors declared a quarterly cash dividend on the Bank’s common stock of $0.42 per share, up $0.01, or 2.44% from the prior quarter. The common stock dividend is payable on January 21, 2025 to shareholders of record as of January 14, 2025. Bank OZK has increased its quarterly cash dividend on its common stock in each of the last fifty-eight quarters.


January 3, 2025




Articles that caught my attention:





Thanks for stopping by!


Posted by
Labels: , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)